X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1576) 1576
Patent (102) 102
Publication (77) 77
Conference Proceeding (44) 44
Book Review (27) 27
Book Chapter (20) 20
Book / eBook (18) 18
Dissertation (11) 11
Magazine Article (3) 3
Newspaper Article (3) 3
Report (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (502) 502
index medicus (471) 471
male (368) 368
female (336) 336
animals (251) 251
middle aged (243) 243
aged (182) 182
adult (178) 178
endocrinology & metabolism (143) 143
diabetes (111) 111
analysis (106) 106
research (103) 103
chemistry (90) 90
cardiac & cardiovascular systems (86) 86
risk factors (85) 85
medicine & public health (77) 77
cell biology (73) 73
metallurgy (71) 71
dogs (66) 66
care and treatment (65) 65
type 2 diabetes (65) 65
disease (64) 64
biochemistry & molecular biology (63) 63
mice (61) 61
diabetes mellitus (58) 58
medicine (58) 58
peripheral vascular disease (58) 58
expression (57) 57
treatment outcome (57) 57
risk (56) 56
studies (56) 56
organic chemistry (55) 55
health aspects (54) 54
human necessities (54) 54
chemistry, inorganic & nuclear (53) 53
immunology (53) 53
physiological aspects (52) 52
microbiology (51) 51
parasitology (51) 51
prospective studies (49) 49
diabetic foot (48) 48
prevalence (48) 48
diagnosis (47) 47
rats (46) 46
time factors (45) 45
activation (44) 44
glucose (44) 44
infectious diseases (44) 44
oncology (44) 44
adolescent (43) 43
pharmacology & pharmacy (43) 43
research article (43) 43
materials science, multidisciplinary (42) 42
mellitus (42) 42
biomedicine (41) 41
cardiology (41) 41
cross-sectional studies (41) 41
internal medicine (41) 41
ischemia (41) 41
proteins (41) 41
agriculture (40) 40
arteriogenesis (40) 40
surgery (40) 40
mortality (39) 39
angiogenesis (37) 37
cardiovascular disease (37) 37
cardiovascular diseases (37) 37
follow-up studies (37) 37
neurosciences (37) 37
complications (36) 36
fishing (36) 36
heterocyclic compounds (36) 36
animal husbandry (35) 35
biocides, e.g. as disinfectants, as pesticides, as herbicides (35) 35
forestry (35) 35
hunting (35) 35
chemistry, multidisciplinary (34) 34
pest repellants or attractants (34) 34
plant growth regulators (34) 34
preservation of bodies of humans or animals or plants or partsthereof (34) 34
trapping (34) 34
aged, 80 and over (33) 33
blood pressure (33) 33
children (33) 33
hypertension (33) 33
medical and health sciences (33) 33
medicin och hälsovetenskap (33) 33
multidisciplinary sciences (33) 33
myocardium - metabolism (33) 33
regression analysis (33) 33
swine (33) 33
hygiene (32) 32
insulin (32) 32
management (32) 32
medical microbiology (32) 32
prevention (32) 32
cohort studies (31) 31
heart (31) 31
immunohistochemistry (31) 31
medical research (31) 31
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
Gerstein Science - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1599) 1599
German (150) 150
French (76) 76
Portuguese (8) 8
Dutch (7) 7
Spanish (3) 3
Danish (1) 1
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Ogawa, H and Koyanagi, R and Kawada-Watanabe, E and Yamaguchi, J and Takagi, A and Hagiwara, N and Deedwania, P. C and Demicco, D. A and Breazna, A and Wun, C. C and Pedersen, T and Colhoun, H. M and Neil, A and Hitman, G and Nakanishi, K and Fukuda, S and Shimada, K and Ehara, S and Inanami, H and Matsumoto, K and Taguchi, H and Muro, T and Yoshikawa, J and Yoshiyama, M and Dimitriadis, K and Tsioufis, C and Tatsis, I and Chlapoutakis, G and Lioni, L and Tzamou, V and Kasiakogias, A and Thomopoulos, C and Tousoulis, D and Stefanadis, C and Terentes-Printzios, D and Vlachopoulos, C and Aznaouridis, K and Ioakeimidis, N and Parapid, B and Vukcevic, V and Obrenovic-Kircanski, B and Simic, D. V and Milic, N. M and Stojanov, V and Beleslin, B and Nedeljkovic, I and Nedeljkovic-Arsenovic, O. M. S and Ostojic, M. C and Kotecha, D and Krum, H and New, G and Eccleston, D and Collins, P and Flather, M and Pepper, J and Tomiyama, H and Odaira, M and Yoshida, M and Shiina, K and Matsumoto, C and Yamashina, A and Pastormerlo, L. E and Maffei, S and Chubuchny, V and Mazzone, A. M and Susini, C and Passino, C and Chiappino, D and Emdin, M and Clerico, A and Katsi, V and Souretis, G and Vlasseros, I and Vrachatis, D and Kallikazaros, I and Androulakis, E and Chatzistamatiou, E and Papageorgiou, N and Miliou, A and Siasos, G and Moustakas, G and Ochoa, J. E and Balparda, J. K and Correa, M. M and Valencia, A. M and Alvarez, M and Mcewen, J. G and Bilo, G and Salvi, P and Aristizabal, D and Parati, G and De Vries, H and Engen-Verheul, M and Kemps, H. M. C and Kraaijenhagen, R and Peek, N and Vervueren, P. L and Bongard, V and Arveiler, D and Dallongeville, J and ... and on behalf of GEMI Group and on behalf of Korean Acute Myocardial Infarction Registry and on behalf of SWEETHEART-Study-Group and on behalf of QuIK Steering Committee and on behalf of On Behalf of the MADIT-CRT Investigators and on behalf of NAGOYA HEART Study Group and on behalf of Kan Wang, Xiaosheng Hu, Changqing Du, Shike Tu, Furong Zhang, and Xudong Xie and on behalf of The FRANCE2 scientific Committee and on behalf of Oslo Ischemia Study Group and on behalf of EUROVISION investigators and on behalf of German transcatheter aortic valve interventions registry and on behalf of Tokyo CCU network Committee and on behalf of Neha Singh and on behalf of the CASE-J Ex Study Group and on behalf of On behalf of Preserved-DATA-HELP (Diagnostic And TherApeutic methods, used in patients with systolic HEart failure, Living in Poland) investigators and on behalf of Associazione per lo Studio della Trombosi in Cardiologia and on behalf of BRAVO Investigators and on behalf of TIMI Study Group and on behalf of The Swedish Heart Failure Registry and on behalf of German Competence Network of Heart Failure and on behalf of Nordic ARVC Registry and on behalf of ACUITY and HORIZONS AMI and on behalf of Biomarkers in Cardiology and on behalf of Portuguese Registry of Acute Coronary Syndromes Investigators and on behalf of IMPROVE study group and on behalf of CLARICOR and on behalf of Department of Cardiology, Jinan Central Hospital Affiliated to Shandong University and on behalf of STAR-Study-Group and on behalf of DiaRegis-Study-Group and on behalf of MASS II Trial and on behalf of The Rotterdam Study and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of SACRA and PLUM registries investigators and on behalf of SMILE-4 and on behalf of AMIS Plus Investigators and on behalf of Gutenberg Heart Study and on behalf of VIPER-BP Study Investigators and on behalf of Hypersleep and on behalf of The CHART-2 Investigators and on behalf of HIJ-CREATE and on behalf of Joint "Croix Rouge Francaise" and "Federation Francaise de Cardiologie" Study Investigators and on behalf of ACTION and on behalf of EHS-PCI-Registry Study Group and on behalf of CCMR-3B Study Investigators and on behalf of The EURIKA investigators and on behalf of The GARFIELD Investigators and on behalf of a name and on behalf of RESET study investigators and on behalf of the SchlaHF-Investigators and on behalf of VIPER-BP Investigators and on behalf of ISSUE3 investigators and on behalf of FOCUS registry investigators and on behalf of NEO study and on behalf of cardiology unit, Ramathibodi hospital and on behalf of First Division of Cardiovascular Department, Chang Gung Memorial Hospital, Linkou and on behalf of Kyoto University/Canon joint research project and on behalf of The REACH registry investigators and on behalf of GCKD Study Investigators and on behalf of College National des Cardiologues des Hopitaux francais and on behalf of BBK registry Bad Krozingen and on behalf of PL-ACS Investigators and on behalf of the Three-City study Group and on behalf of Apixaban for Reduction In STroke and Other ThromboemboLic Events in Atrial Fibrillation and on behalf of ARISTOTLE Investigators and Committees and on behalf of Heart Cycle and on behalf of Electrophysiologist International Community "EPIC" Alliance and on behalf of MOMOTARO study and on behalf of BOREAS-TCM study and on behalf of BIOSOLVE-I Investigators and on behalf of On behalf of DATA-HELP study (Diagnostic And TherApeutic methods, used in patients with systolic HEart failure, Living in Poland) investigators and on behalf of FINN-AKVA study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 655 - 939
Journal Article
by Veitenhansl, M and Stegner, K and Hierl, F.-X and Dieterle, C and Feldmeier, H and Gutt, B and Landgraf, R and Garrow, A P and Vileikyte, L and Findlow, A and Waterman, C and Boulton, A J. M and Shankhdhar, K and Shankhdhar, L and Shankhdhar, U and Petrova, N L and Foster, A V. M and Edmonds, M E and Ferraresi, R and Caravaggi, C and De Giglio, R and Cavaiani, P and Pogliaghi, I and Sommariva, E and Katz, I A and Harlan, A and Miranda-Palma, B and Prieto-Sanchez, L and Armstrong, D G and Bowker, J H and Mizel, M S and Cernea, S and Wohlgelernter, J and Kidron, M and Modi, P and Raz, I and Arbit, E and Nosek, L and Kapitza, C and Beckett, P and Gelfand, R and Goldberg, M and Heise, T and Testa, M A and Turner, R R and Hayes, J F and Scranton, R E and Simonson, D C and Yang, Y.-W and Hsu, Y.-J and Naujok, O and Francini, F and Jörns, A and Tiedge, M and Lenzen, S and Abdel-Wahab, Y H. A and Marenah, L and Orr, D F and Shaw, C and Flatt, P R and Chokkalingam, K and Mansell, P I and Clausen, P and Ekbom, P and Damm, P and Feldt-Rasmussen, U and Nielsen, B and Mathiesen, E R and Feldt-Rasmussen, B and Dewan, S and Da Silva, N and Ternan, P Mc and Leong, K S and Wilding, J P. H and Asatiani, N and Kurashvili, R and Dundua, M and Shelestova, E and Pagava, K and Ramazashvili, M and Hod, M and Smirnov, S and Petersen, J L. A and Justesen, T I and Ringholm Nielsen, L and Müller, C and Højlund, K and Wensaas, A and Kase, E T and Aas, V and Rustan, A C and Thoresen, G H and Levin, K and Beck-Nielsen, H and Gaster, M and Im, S.-S and Kang, S.-Y and Kim, S.-Y and Ahn, Y.-H and Lihn, A S and ... and The RECORD Study Group and AUDIT Investigators and DIABHYCAR Study Group and The FinnDiane Study Group and KANWU Study Group and FinnDiane Study Group and Spanish Group of MODY (GEM) and Fidarestat Study Group and HOE901/4009 Study Group and AT.LANTUS Study Group and Turkish Diabetes Centers Study Group and KORA Group and Group D.E.S.I.R and North West Adelaide Health Study Team and Euro Heart Survey Investigators and Belgian Diabetes Registry (Brussels, Belgium) and AT:LANTUS Study Group and Israel Diabetes Research Group (IDRG) and The ASDIAB Study Group and G. IMDIAB and 205-Nations Study Group and IMDIAB Group and EURODIAB PCS Group and Italian Repaglinide Study Group and DPV-Wiss-Study Group
Diabetologia, ISSN 0012-186X, 8/2004, Volume 47, Issue S1, pp. A1 - A464
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
by Bosch, Jackie and Gerstein, Hertzel C and Dagenais, Gilles R and Díaz, Rafael and Dyal, Leanne and Jung, Hyejung and Maggiono, Aldo P and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, Leanne and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
MEDICINE, GENERAL & INTERNAL | EVENTS | PREVENTION | FISH | RISK | CORONARY-HEART-DISEASE | OMEGA-3-FATTY-ACID INTAKE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article